[1] ACHESON J F. Idiopathic intracranial hypertension

and visual function[J/OL]. Br Med Bull，2006，79-80：

233-244. https：//doi.org/10.1093/bmb/ldl019.

[2] THURTELL M J，WALL M. Idiopathic intracranial

hypertension（pseudotumor cerebri）：recognition，

treatment，and ongoing management[J]. Curr Treat

Options Neurol，2013，15（1）：1-12.

[3] SATTI S R，LEISHANGTHEM L，SPIOTTA A，

et al. Dural venous sinus stenting for medically

and surgically refractory idiopathic intracranial

hypertension[J]. Interv Neuroradiol，2017，23（2）：

186-193.

[4] MOLLAN S P，ALI F，HASSAN-SMITH G，et al.

Evolving evidence in adult idiopathic intracranial

hypertension：pathophysiology and management[J].

J Neurol Neurosurg Psychiatry，2016，87（9）：982-

992.

[5] SHIELDS L B E，SHIELDS C B，YAO T L，et

al. Endovascular treatment for venous sinus

stenosis in idiopathic intracranial hypertension：an

observational study of clinical indications，surgical

technique，and long-term outcomes[J/OL]. World

Neurosurg，2019，121：e165-e171. https：//doi.

org/10.1016/j.wneu.2018.09.070.

[6] LIU K C，STARKE R M，DURST C R，et al.

Venous sinus stenting for reduction of intracranial

pressure in IIH：a prospective pilot study[J]. J

Neurosurg，2017，127（5）：1126-1133.

[7] LEISHANGTHEM L，SIRDESHPANDE P，DUA

D，et al. Dural venous sinus stenting for idiopathic

intracranial hypertension：an updated review[J]. J

Neuroradiol，2019，46（2）：148-154.

[8] PORTELLI M，PAPAGEORGIOU P N. An update on idiopathic intracranial hypertension[J]. Acta

Neurochir（Wien），2017，159（3）：491-499.

[9] FARB R I，VANEK I，SCOTT J N，et al. Idiopathic

intracranial hypertension：the prevalence and

morphology of sinovenous stenosis[J]. Neurology，

2003，60（9）：1418-1424.

[10] KUMPE D A，BENNETT J L，SEINFELD J，et

al. Dural sinus stent placement for idiopathic

intracranial hypertension[J]. J Neurosurg，2012，116

（3）：538-548.

[11] ALBUQUERQUE F C，DASHTI S R，HU Y C，et

al. Intracranial venous sinus stenting for benign

intracranial hypertension：clinical indications，

technique，and preliminary results[J]. World

Neurosurg，2011，75（5-6）：648-652；discussion

592-595.

[12] OWLER B K，PARKER G，HALMAGYI G M，et al.

Cranial venous outflow obstruction and pseudotumor

cerebri syndrome[J/OL]. Adv Tech Stand Neurosurg，

2005，30：107-174. https：//doi.org/10.1007/3-211-

27208-9_4.

[13] BUSSIÈRE M，FALERO R，NICOLLE D，et al.

Unilateral transverse sinus stenting of patients with

idiopathic intracranial hypertension[J]. AJNR Am J

Neuroradiol，2010，31（4）：645-650.

[14] AHMED R M，WILKINSON M，PARKER G

D，et al. Transverse sinus stenting for idiopathic

intracranial hypertension：a review of 52 patients

and of model predictions[J]. AJNR Am J Neuroradiol，

2011，32（8）：1408-1414.

[15] FARGEN K M，SPIOTTA A M，HYER M，et al.

Comparison of venous sinus manometry gradients

obtained while awake and under general anesthesia

before venous sinus stenting[J]. J Neurointerv Surg，

2017，9（10）：990-993.

[16] RAPER D M S，BUELL T J，CHEN C J，et al.

Intracranial venous pressures under conscious

sedation and general anesthesia[J]. J Neurointerv

Surg，2017，9（10）：986-989.

[17] GUO X B，WEI S，GUAN S. Intracranial venous

pressures manometry for patients with idiopathic

intracranial hypertension：under awake setting or

general anesthesia[J/OL]. Front Neurol，2019，10：

751. https：//doi.org/10.3389/fneur.2019.00751.

[18] DURGAN D J，BRYAN R M Jr. Cerebrovascular

consequences of obstructive sleep apnea[J/OL]. J

Am Heart Assoc，2012，1（4）：e000091. https：//doi.

org/10.1161/JAHA.111.000091.

[19] WEST J L，GARNER R M，TRAUNERO J R，et

al. Changes in end-tidal carbon dioxide partial

pressure alter venous sinus pressure measurements

in idiopathic intracranial hypertension[J/OL].

World Neurosurg，2018，120：495-499. https：//doi.

org/10.1016/j.wneu.2018.09.117.

[20] AVERY M B，SAMBRANO S，KHADER ELIYAS

J，et al. Accuracy and precision of venous pressure

measurements of endovascular microcatheters

in the setting of dural venous sinus stenosis[J]. J

Neurointerv Surg，2018，10（4）：387-391.

[21] LOPES D K，JOHNSON A K，TAN L A. Venous

sinus manometry and intervention using the

PrimeWire Prestige pressure guidewire：technique

and initial experience[J]. J Neurointerv Surg，2013，5

（5）：458-460.

[22] LENCK S，VALLÉE F，CIVELLI V，et al.

Assessment of blood flow velocities and venous

pressures using a dual-sensor guidewire in

symptomatic dural sinus stenoses[J/OL]. J Neurosurg，

2018：1-5. https：//doi.org/10.3171/2017.12.

JNS172364.

[23] FARGEN K M，LIU K，GARNER R M，et al.

Recommendations for the selection and treatment of

patients with idiopathic intracranial hypertension for

venous sinus stenting[J]. J Neurointerv Surg，2018，

10（12）：1203-1208.

[24] HIGGINS J N，OWLER B K，COUSINS C，et

al. Venous sinus stenting for refractory benign

intracranial hypertension[J]. Lancet，2002，359

（9302）：228-230.

[25] DINKIN MJ，PATSALIDES A. Venous sinus

stenting in idiopathic intracranial hypertension：

results of a prospective trial[J]. J Neuroophthalmol，

2017，37（2）：113-121.

[26] STARKE R M，WANG T，DING D，et al.

Endovascular treatment of venous sinus stenosis in

idiopathic intracranial hypertension：complications，

neurological outcomes，and radiographic results[J/

OL]. Scientific World Journal，2015，2015：140408.

https：//doi.org/10.1155/2015/140408.

[27] SABER H，LEWIS W，SADEGHI M，et al. Stent

survival and stent-adjacent stenosis rates following

venous sinus stenting for idiopathic intracranial

hypertension：a systematic review and metaanalysis[

J]. Interv Neurol，2018，7（6）：490-500.

[28] SKAU M，GOETZE J P，REHFELD J F，et al.

Natriuretic pro-peptides in idiopathic intracranial

hypertension[J]. Regul Pept，2010，164（2-3）：71-77.

[29] PATSALIDES A，OLIVEIRA C，WILCOX J，et

al. Venous sinus stenting lowers the intracranial

pressure in patients with idiopathic intracranial

hypertension[J]. J Neurointerv Surg，2019，11（2）：

175-178.

[30] DAGGUBATI L C，LIU K C. Intracranial venous

sinus stenting：a review of idiopathic intracranial

hypertension and expanding indications[J/

OL]. Cureus，2019，11（2）：e4008. https：//doi.

org/10.7759/cureus.4008.

[31] FIELDS J D，JAVEDANI P P，FALARDEAU J，et al.

Dural venous sinus angioplasty and stenting for the

treatment of idiopathic intracranial hypertension[J].

J Neurointerv Surg，2013，5（1）：62-68.

[32] BRAZIS P W. Clinical review：the surgical treatment

of idiopathic pseudotumour cerebri（idiopathic

intracranial hypertension）[J]. Cephalalgia，2008，28

（12）：1361-1373.

[33] MUKHERJEE N，BHATTI M T. Update on the

surgical management of idiopathic intracranial

hypertension[J]. Curr Neurol Neurosci Rep，2014，14

（3）：438.

[34] URETSKY S. Surgical interventions for idiopathic

intracranial hypertension[J]. Curr Opin Ophthalmol，

2009，20（6）：451-455.

[35] SPOOR T C，MCHENRY J G. Long-term

effectiveness of optic nerve sheath decompression

for pseudotumor cerebri[J]. Arch Ophthalmol，1993，

111（5）：632-635.

[36] TARNARIS A，TOMA A K，WATKINS L D，et

al. Is there a difference in outcomes of patients with

idiopathic intracranial hypertension with the choice

of cerebrospinal fluid diversion site：a single centre

experience[J]. Clin Neurol Neurosurg，2011，113（6）：

477-479.

[37] FELDON S E. Visual outcomes comparing surgical

techniques for management of severe idiopathic

intracranial hypertension[J/OL]. Neurosurg Focus，

2007，23（5）：E6. https：//doi.org/10.3171/FOC-

07/11/E6.

[38] SATTI S R，LEISHANGTHEM L，CHAUDRY M I.

Meta-analysis of CSF diversion procedures and dural

venous sinus stenting in the setting of medically

refractory idiopathic intracranial hypertension[J].

AJNR Am J Neuroradiol，2015，36（10）：1899-1904.

[39] SURI A，PANDEY P，MEHTA V S. Subarachnoid

hemorrhage and intracereebral hematoma following

lumboperitoneal shunt for pseudotumor cerebri：a

rare complication[J]. Neurol India，2002，50（4）：

508-510.

[40] CAPPUZZO J M，HESS R M，MORRISON J F，et

al. Transverse venous stenting for the treatment of

idiopathic intracranial hypertension，or pseudotumor

cerebri[J/OL]. Neurosurg Focus，2018，45（1）：E11.

https：//doi.org/10.3171/2018.5.FOCUS18102.